- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 53.18 | -6.59 | 11.4 | 0 | 0 | 0 | 0.82 | 49.09 | 5.13 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.54 | 59.6 | -5.63 | 0.00 | 0 | 0 | 181 | 0.56 | 9.7 |
| 23Q3 (19) | 56.93 | 3.0 | 15.27 | 0 | 0 | 0 | 0.55 | 5.77 | 1.85 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.97 | 2.69 | -11.64 | 0.00 | 0 | 0 | 180 | 2.27 | 10.43 |
| 23Q2 (18) | 55.27 | 1.6 | -9.32 | 0 | 0 | 0 | 0.52 | -8.77 | -8.77 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.94 | -10.21 | 0.6 | 0.00 | 0 | 0 | 176 | 1.15 | 10.0 |
| 23Q1 (17) | 54.4 | 13.95 | -1.61 | 0 | 0 | 0 | 0.57 | -26.92 | 35.71 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.05 | -35.87 | 37.93 | 0.00 | 0 | 0 | 174 | 5.45 | 9.43 |
| 22Q4 (16) | 47.74 | -3.34 | -1.14 | 0 | 0 | 0 | 0.78 | 44.44 | 14.71 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.63 | 49.44 | 16.03 | 0.00 | 0 | 0 | 165 | 1.23 | 13.79 |
| 22Q3 (15) | 49.39 | -18.97 | 0.67 | 0 | 0 | 0 | 0.54 | -5.26 | 38.46 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.09 | 16.91 | 37.54 | 0.00 | 0 | 0 | 163 | 1.88 | 13.99 |
| 22Q2 (14) | 60.95 | 10.24 | 15.46 | 0 | 0 | 0 | 0.57 | 35.71 | 58.33 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.94 | 23.11 | 37.14 | 0.00 | 0 | 0 | 160 | 0.63 | 13.48 |
| 22Q1 (13) | 55.29 | 14.5 | 1.86 | 0 | 0 | 0 | 0.42 | -38.24 | 0.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.76 | -46.06 | -1.83 | 0.00 | 0 | 0 | 159 | 9.66 | 11.97 |
| 21Q4 (12) | 48.29 | -1.57 | 10.28 | 0 | 0 | 0 | 0.68 | 74.36 | 151.85 | 0 | 0 | 0 | 0.00 | 0 | 0 | 1.41 | 77.14 | 128.38 | 0.00 | 0 | 0 | 145 | 1.4 | 0.0 |
| 21Q3 (11) | 49.06 | -7.07 | 9.07 | 0 | 0 | 0 | 0.39 | 8.33 | 21.88 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.79 | 16.57 | 11.74 | 0.00 | 0 | 0 | 143 | 1.42 | -1.38 |
| 21Q2 (10) | 52.79 | -2.75 | 18.63 | 0 | 0 | 0 | 0.36 | -14.29 | 12.5 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.68 | -11.87 | -5.17 | 0.00 | 0 | 0 | 141 | -0.7 | -2.08 |
| 21Q1 (9) | 54.28 | 23.96 | 25.33 | 0 | 0 | 0 | 0.42 | 55.56 | 13.51 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.77 | 25.49 | -9.43 | 0.00 | 0 | 0 | 142 | -2.07 | 0 |
| 20Q4 (8) | 43.79 | -2.65 | 14.01 | 0 | 0 | 0 | 0.27 | -15.62 | -27.03 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.62 | -13.33 | -35.99 | 0.00 | 0 | 0 | 145 | 0.0 | 0.69 |
| 20Q3 (7) | 44.98 | 1.08 | 10.98 | 0 | 0 | 0 | 0.32 | 0.0 | 0.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.71 | -1.07 | -9.89 | 0.00 | 0 | 0 | 145 | 0.69 | -1.36 |
| 20Q2 (6) | 44.5 | 2.75 | 10.75 | 0 | 0 | 0 | 0.32 | -13.51 | 6.67 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.72 | -15.83 | -3.69 | 0.00 | 0 | 0 | 144 | 0 | -2.7 |
| 20Q1 (5) | 43.31 | 12.76 | 3.59 | 0 | 0 | 0 | 0.37 | 0.0 | 2.78 | 0 | 0 | 0 | 0.00 | 0 | 0 | 0.85 | -11.31 | -0.78 | 0.00 | 0 | 0 | 0 | -100.0 | -100.0 |
| 19Q4 (4) | 38.41 | -5.23 | 0.0 | 0 | 0 | 0.0 | 0.37 | 15.62 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 0.96 | 22.01 | 0.0 | 0.00 | 0 | 0.0 | 144 | -2.04 | 0.0 |
| 19Q3 (3) | 40.53 | 0.87 | 0.0 | 0 | 0 | 0.0 | 0.32 | 6.67 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 0.79 | 5.75 | 0.0 | 0.00 | 0 | 0.0 | 147 | -0.68 | 0.0 |
| 19Q2 (2) | 40.18 | -3.9 | 0.0 | 0 | 0 | 0.0 | 0.3 | -16.67 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 0.75 | -13.29 | 0.0 | 0.00 | 0 | 0.0 | 148 | 4.23 | 0.0 |
| 19Q1 (1) | 41.81 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.36 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 0.86 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 142 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 219.78 | 3.0 | 0 | 0 | 2.46 | 6.96 | 0 | 0 | 0.00 | 0 | 1.12 | 3.84 | 0.00 | 0 | 181 | 9.7 |
| 2022 (9) | 213.38 | 4.39 | 0 | 0 | 2.3 | 24.32 | 0 | 0 | 0.00 | 0 | 1.08 | 19.1 | 0.00 | 0 | 165 | 13.79 |
| 2021 (8) | 204.41 | 15.77 | 0 | 0 | 1.85 | 44.53 | 0 | 0 | 0.00 | 0 | 0.91 | 24.85 | 0.00 | 0 | 145 | 0.0 |
| 2020 (7) | 176.57 | 9.72 | 0 | 0 | 1.28 | -5.88 | 0 | 0 | 0.00 | 0 | 0.72 | -14.22 | 0.00 | 0 | 145 | 0.69 |
| 2019 (6) | 160.93 | 8.21 | 0 | 0 | 1.36 | 1.49 | 0 | 0 | 0.00 | 0 | 0.85 | -6.21 | 0.00 | 0 | 144 | 3.6 |
| 2018 (5) | 148.72 | 1.86 | 0 | 0 | 1.34 | -15.19 | 0 | 0 | 0.00 | 0 | 0.90 | -16.74 | 0.00 | 0 | 139 | 0.0 |
| 2017 (4) | 146.0 | 8.6 | 0 | 0 | 1.58 | 37.39 | 0 | 0 | 0.00 | 0 | 1.08 | 26.51 | 0.00 | 0 | 139 | 2.21 |
| 2016 (3) | 134.44 | -4.44 | 0 | 0 | 1.15 | -2.54 | 0 | 0 | 0.00 | 0 | 0.86 | 1.98 | 0.00 | 0 | 136 | -2.16 |
| 2015 (2) | 140.68 | -13.61 | 0 | 0 | 1.18 | 2.61 | 0 | 0 | 0.00 | 0 | 0.84 | 18.77 | 0.00 | 0 | 139 | -0.71 |
| 2014 (1) | 162.84 | 5.85 | 0 | 0 | 1.15 | 11.65 | 0 | 0 | 0.00 | 0 | 0.71 | 0 | 0.00 | 0 | 140 | 0.0 |
